What is Oncotarget?
Oncotarget is a journal that has free public access. The journal is multidisciplinary which means it contains several different academic disciplines or professional specializations. Mikhail Blagosklonny and Andrei V. Gudkov are the editors-in-chief
The term Oncotarget encloses all molecules, pathways, and cellular functions common in cancer and aging, neurodegeneration and atherosclerosis, lymphocytes and neurons, cancer cells and microbes. Now the general public has access to the latest advancement in various medical fields.
How is Oncotarget helping the world
Their mission on Oncotarget is to make scientific results available promptly to the general public. What does this do? Well, it maximizes the impact of the results. For instance a research paper is released. Another professional reads it and shares useful incite to the author. The author then comes to an important conclusion due to the interaction. This just basically is a unique way to speed up progress. This might not seem so significant but the possibilities for advancement are endless. It connects top professionals in various fields. They can learn from others in their field or get valuable incite from specialists in other areas. Thanks to Oncotarget you can access thousands of research papers and get the latest information from top professionals for free! Download output styles at Endnote.com
Some of the most recent publications have revealed important discoveries in the oncology field. Recently, The University of Salford made an exciting discovery. A new strategic experiment revealed that a combination of vitamin c and antibiotics can be used to prevent drug resistance in cancer patients. This is just one of many new innovations revealed to thanks to Oncotarget.